Ionis Pharmaceuticals
IONS
IONS
351 hedge funds and large institutions have $5.61B invested in Ionis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 119 increasing their positions, 118 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
351
Holders Change
+2
Holders Change %
+0.57%
% of All Funds
4.67%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
59
Increased
119
Reduced
118
Closed
50
Calls
$26.1M
Puts
$30.5M
Net Calls
-$4.47M
Net Calls Change
-$17.6M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$127M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$61.7M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$61.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.5M |
| 5 |
BlackRock
New York
|
+$29.8M |
Top Sellers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$69.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$58.2M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$38.7M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$30M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$23.9M |
